ROYALTY PHARMA PLC- CL A (RPRX)

GB00BMVP7Y09 - Common Stock

26.36  -0.04 (-0.15%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to RPRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 45.9. This target is 74.13% above the current price.
RPRX was analyzed by 15 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RPRX.
In the previous month the buy percentage consensus was at a similar level.
RPRX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 26.3628.2847.4345.9063.00 - 7.28% 79.93% 74.13% 139.00%
Up and Down Grades
Date Firm Action Rating
2024-10-25 Citigroup Maintains Buy -> Buy
2024-08-14 Goldman Sachs Maintains Buy -> Buy
2024-07-11 Morgan Stanley Maintains Overweight -> Overweight
2024-06-03 UBS Downgrade Buy -> Neutral
2024-04-12 B of A Securities Maintains Buy -> Buy
2024-02-20 JP Morgan Maintains Overweight -> Overweight
2024-02-20 Goldman Sachs Maintains Buy -> Buy
2023-11-09 Morgan Stanley Maintains Overweight -> Overweight
2023-10-11 Morgan Stanley Maintains Overweight -> Overweight
2023-08-09 Morgan Stanley Maintains Overweight -> Overweight
2023-07-11 Morgan Stanley Reiterate Overweight -> Overweight
2023-05-10 Morgan Stanley Maintains Overweight
2023-04-10 Morgan Stanley Maintains Overweight
2023-02-16 UBS Maintains Buy
2022-12-06 Morgan Stanley Maintains Overweight
2022-11-09 Morgan Stanley Maintains Overweight
2022-10-18 JP Morgan Maintains Overweight
2022-08-08 Morgan Stanley Maintains Overweight
2022-07-14 Tigress Financial Maintains Buy
2022-06-14 UBS Initiate Buy
2022-05-13 ScotiaBank Initiate Outperform
2022-04-27 Goldman Sachs Initiate Buy
2022-04-14 JP Morgan Upgrade Neutral -> Overweight
2021-10-29 Citigroup Upgrade Neutral -> Buy
2021-08-16 Morgan Stanley Maintains Equal-Weight
2021-07-30 Tigress Financial Initiate Buy